Gerresheimer AG
XETRA:GXI
Intrinsic Value
Gerresheimer AG manufactures and supplies glass and plastic products for the pharmaceutical and healthcare industry. [ Read More ]
The intrinsic value of one GXI stock under the Base Case scenario is 151.78 EUR. Compared to the current market price of 100.5 EUR, Gerresheimer AG is Undervalued by 34%.
Valuation Backtest
Gerresheimer AG
Run backtest to discover the historical profit from buying and selling GXI stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Balance Sheet Decomposition
Gerresheimer AG
Current Assets | 865.2m |
Cash & Short-Term Investments | 123.2m |
Receivables | 383.2m |
Other Current Assets | 358.9m |
Non-Current Assets | 2.6B |
Long-Term Investments | 31.8m |
PP&E | 1.3B |
Intangibles | 1.3B |
Other Non-Current Assets | 19.3m |
Current Liabilities | 973.2m |
Accounts Payable | 322.4m |
Accrued Liabilities | 13.3m |
Other Current Liabilities | 637.6m |
Non-Current Liabilities | 1.1B |
Long-Term Debt | 651.4m |
Other Non-Current Liabilities | 407.1m |
Earnings Waterfall
Gerresheimer AG
Revenue
|
2B
EUR
|
Cost of Revenue
|
-1.4B
EUR
|
Gross Profit
|
592.9m
EUR
|
Operating Expenses
|
-378.6m
EUR
|
Operating Income
|
214.3m
EUR
|
Other Expenses
|
-97.2m
EUR
|
Net Income
|
117.1m
EUR
|
Free Cash Flow Analysis
Gerresheimer AG
What is Free Cash Flow?
GXI Profitability Score
Profitability Due Diligence
Gerresheimer AG's profitability score is 50/100. The higher the profitability score, the more profitable the company is.
Score
Gerresheimer AG's profitability score is 50/100. The higher the profitability score, the more profitable the company is.
GXI Solvency Score
Solvency Due Diligence
Gerresheimer AG's solvency score is 42/100. The higher the solvency score, the more solvent the company is.
Score
Gerresheimer AG's solvency score is 42/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
GXI Price Targets Summary
Gerresheimer AG
According to Wall Street analysts, the average 1-year price target for GXI is 133.07 EUR with a low forecast of 115.14 EUR and a high forecast of 210 EUR.
Shareholder Return
GXI Price
Gerresheimer AG
Average Annual Return | 3.04% |
Standard Deviation of Annual Returns | 23.51% |
Max Drawdown | -52% |
Market Capitalization | 3.5B EUR |
Shares Outstanding | 34 540 000 |
Percentage of Shares Shorted |
N/A
|
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
Gerresheimer AG manufactures and supplies glass and plastic products for the pharmaceutical and healthcare industry. The company is headquartered in Dusseldorf, Nordrhein-Westfalen and currently employs 10,625 full-time employees. The company went IPO on 2007-06-11. The company operates through two business segments: Plastics and Devices, and Primary Packaging Glass. The Plastics and Devices segment produces standard and customized products for drug delivery, such as insulin pens, inhalers, and prefillable syrings. The Primary Packaging Glass segment focuses on the production of packaging of glass for medicines and cosmetics, such as pharmaceuticals jars, ampoules, injection vials, cartridges, perfume flacons and cream jars, as well as glass containers for the food and beverage industry. The firm operates approximately 40 production facilities in Europe, North America, South America and Asia.
Contact
IPO
Employees
Officers
The intrinsic value of one GXI stock under the Base Case scenario is 151.78 EUR.
Compared to the current market price of 100.5 EUR, Gerresheimer AG is Undervalued by 34%.